{"id":12053,"date":"2019-08-27T16:40:53","date_gmt":"2019-08-27T16:40:53","guid":{"rendered":"https:\/\/iach2019.cme-congresses.com\/?page_id=12053"},"modified":"2019-08-27T16:59:28","modified_gmt":"2019-08-27T16:59:28","slug":"poster-presentations","status":"publish","type":"page","link":"https:\/\/iach2019.cme-congresses.com\/poster-presentations\/","title":{"rendered":"Poster Presentations"},"content":{"rendered":"

\n\t\t\t\t\t
\n\t\t\t\t\t\t

Poster Presentations<\/h2><\/div>
<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div>
\n\t\t\t\t\t
\n\t\t\t\t\t\t\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Board no.<\/span><\/p>\n<\/td>\n

\n

Poster title <\/span><\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/span><\/p>\n<\/td>\n

\n

IMMUNE CHECKPOINTS IN PRIMARY\u00a0IMMUNE THROMBOCYTOPAENIA (ITP): FROM BENCH TO BEDSIDE<\/span><\/b><\/a><\/p>\n

Sasfia<\/span><\/b><\/span><\/span> Candrianita<\/span><\/b><\/span>1<\/span><\/sup><\/b><\/span>,2<\/span><\/sup><\/span>; A<\/span>nwar A. S<\/span>ayed<\/span><\/span>1,3<\/span><\/sup><\/span>; R<\/span>udi <\/span>Supriyadi<\/span><\/span>4<\/span><\/sup><\/span>; N<\/span>ichola <\/span>Cooper1<\/sup><\/span><\/span>,5<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Centre for Haematology<\/span>,\u00a0Imperial College London, London, U<\/span><\/i><\/span>K<\/span><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>Immunology Study Centre, Faculty of Medicine, Universitas<\/span> Padjadjaran<\/span>,
\nBandung, Indonesia<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>Department of Medical Microbiology and Immunology,\u00a0Taibah University, Medina, Saudi Arabia<\/span><\/i><\/span>, <\/span><\/i>4<\/span><\/sup><\/i><\/span>Department of Internal Medicine, Dr. Hasan Sadikin<\/span> General Hospital \/ Faculty of Medicine, Universitas<\/span> Padjadjaran<\/span>,\u00a0Bandung, Indonesia<\/span><\/i><\/span>, <\/span><\/i>5<\/span><\/sup><\/span>Department of Haematology<\/span>, Hammersmith Hospital, Imperial College\u00a0Healthcare NHS Trust, London, U<\/span><\/i><\/span>K<\/span><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

2<\/span><\/p>\n<\/td>\n

\n

Systematic\u00a0review of tyrosine kinase inhibitors (TKI) for the treatment of chronic\u00a0myeloid leukemia (CML) and Philadelphia-chromosome-positive acute\u00a0lymphoblastic leukemia (Ph+ ALL) with resistance to at least one prior TKI<\/span><\/b><\/a><\/p>\n

E<\/span><\/b><\/span>va Susanne <\/span><\/b><\/span>Dietrich<\/span><\/b><\/span>1<\/span><\/sup><\/span>; Andrea <\/span>Rathmann-Schmitz<\/span><\/span>2<\/span><\/sup><\/span>; Veronika <\/span>Schneck<\/span><\/span>2<\/span><\/sup><\/span>; Christina <\/span>Keksel<\/span><\/span>2<\/span><\/sup><\/span>; Oliver <\/span>Sch\u00f6nborn-Kellenberger<\/span><\/span>3<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Institute for Evidence-based Positioning in Healthcare,<\/span><\/i><\/span> Germany<\/span><\/i><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>MEDAHCON GmbH<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>Cogitars GmbH<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

3<\/span><\/p>\n<\/td>\n

\n

COMPARATIVE ANALYSIS OF\u00a0ENOXAPARIN VERSUS RIVAROXABAN IN THE TREATMENT OF CANCER ASSOCIATED
\nVENOTHROMBOEMBOLISM: EXPERIENCE FROM A TERTIARY CARE CANCER CENTER<\/span><\/b><\/a><\/p>\n

Anadil<\/span><\/b><\/span> Faqah<\/span><\/span><\/b>, Hassan Sheikh; Muhammad <\/span>Abubakar; <\/span>Fatima Tayyaab<\/span>; Sahrish<\/span> <\/span>Khawaja<\/span><\/p>\n

Shaukat\u00a0Khanum Memorial Cancer Hospital & Research Center, Pakistan<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

4<\/span><\/p>\n<\/td>\n

\n

EFFICACY AND SAFETY OF\u00a0DEFIBROTIDE IN THE TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE\/SINUSOIDAL
\nOBSTRUCTION SYNDROME FOLLOWING HAEMATOPOIETIC CELL TRANSPLANTATION: INTERIM\u00a0RESULTS FROM THE DEFIFRANCE STUDY<\/span><\/b><\/a><\/p>\n

A<\/span><\/b><\/span>nne <\/span><\/b><\/span>Huynh<\/span><\/b><\/span>1<\/span><\/sup><\/span>; Myriam <\/span>Labopin<\/span><\/span>2<\/span><\/sup><\/span>; Ibrahim <\/span>Yakoub-Agha<\/span><\/span>3<\/span><\/sup><\/span>; Didier <\/span>Blaise<\/span><\/span>4<\/span><\/sup><\/span>; R\u00e9gis<\/span> <\/span>Peffault<\/span><\/span><\/span> de Latour<\/span><\/span>5<\/span><\/sup><\/span>; Virginie <\/span>Bouvatier<\/span><\/span>6<\/span><\/sup><\/span>; D\u00e9borah<\/span> <\/span>Gutierrez<\/span><\/span>6<\/span><\/sup><\/span>; Jean-Hughes <\/span>Dalle<\/span><\/span>7<\/span><\/sup><\/span>; Mohamad <\/span>Mohty<\/span><\/span>2<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Institut Universitaire<\/span> du\u00a0Cancer de Toulouse-Oncopole<\/span>, Toulouse<\/span><\/i><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>H\u00f4pital Saint-Antoine, Paris<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>H\u00f4pital Claude Huriez<\/span>, Lille<\/span><\/i><\/span>, <\/span><\/i>4<\/span><\/sup><\/i><\/span>Institut Paoli Calmettes<\/span>,\u00a0Marseille<\/span><\/i><\/span>, <\/span><\/i>5<\/span><\/sup><\/i><\/span>H\u00f4pital Saint-Louis, Paris<\/span><\/i><\/span>, <\/span><\/i>6<\/span><\/sup><\/i><\/span>Jazz Pharmaceuticals, Lyon<\/span><\/i><\/span>, <\/span><\/i>7<\/span><\/sup><\/i><\/span>H\u00f4pital Robert-Debr\u00e9<\/span>, Paris,\u00a0France<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

5<\/span><\/p>\n<\/td>\n

\n

CNS INVOLVEMENT AT PRESENTATION\u00a0IN AML: A RETROSPECTIVE CASE SERIES<\/span><\/b><\/a><\/p>\n

A<\/span><\/b><\/span>dtil<\/span><\/b><\/span><\/span> <\/b>Jain<\/span><\/b><\/span>; Nivedita <\/span>Dhingra<\/span><\/span>; Tulika<\/span> <\/span>Seth<\/span><\/span>; Manoranjan<\/span> <\/span>Mahapatra<\/span><\/span><\/p>\n

Clinical\u00a0Hematology, AIIMS, New Delhi, Delhi, India<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

6<\/span><\/p>\n<\/td>\n

\n

THIRD PARTY MESENCHYMAL STROMAL\u00a0CELLS FOR THERAPY OF ACUTE GRAFT-VERSUS-HOST DISEASE A SINGLE CENTER
\nEXPERIENCE<\/span><\/b><\/a><\/p>\n

E<\/span><\/b><\/span>va <\/span><\/b><\/span>Mischak-Weissinger<\/span><\/b><\/span><\/span><\/b><\/p>\n

Hannover\u00a0Medical School, Hematology, Hemostasis, Oncology and Stem Cell\u00a0Transplantation, Hannover, Niedersachsen, Germany<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

7<\/span><\/p>\n<\/td>\n

\n

Anti-Leukemic\u00a0Effects of Simvastatin on NRASG12D Mutant Acute Myeloid Leukemia Cells<\/span><\/b><\/a><\/p>\n

S<\/span><\/b><\/span>ilvia <\/span><\/b><\/span>Park<\/span><\/b><\/span>1<\/span><\/sup><\/span>; Jiryeon<\/span> <\/span>Jang<\/span><\/span>2,3<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Department of Internal Medicine, Seoul St. Mary’s\u00a0Hematology Hospital, College of Medicine, The Catholic University of Korea,\u00a0Seoul, Republic of Korea<\/span><\/i><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>Division of Hematology-Oncology, Department of Internal\u00a0Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,
\nSeoul, Korea;<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>Division of\u00a0Hematology-Oncology, Department of Internal Medicine, Pusan National\u00a0University<\/span><\/i><\/span> Yangsan<\/i><\/span> Hospital,
\nPusan National University School of Medicine, Yangsan<\/span>,\u00a0Korea<\/i><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

8<\/span><\/p>\n<\/td>\n

\n

Comparison\u00a0of post-transplant outcome by conditioning intensity in patients with minimal\u00a0residual disease negative acute myeloid leukemia (MRDneg AML)<\/span><\/b><\/a><\/p>\n

S<\/span><\/b><\/span>ilvia <\/span><\/b><\/span>Park<\/span><\/b><\/span>1<\/span><\/sup><\/span>; Byung Sik<\/span> <\/span>Cho<\/span><\/span>2,3<\/span><\/sup><\/span>; Hee<\/span>-Je <\/span>Kim<\/span><\/span>2,3<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Department of Internal Medicine, Seoul St. Mary’s\u00a0Hematology Hospital, College of Medicine, The Catholic University of Korea,\u00a0Seoul, Republic of Korea<\/span><\/i><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>Department of Internal Medicine, Seoul St. Mary’s\u00a0Hematology Hospital, College of Medicine, The Catholic University of Korea,
\nSeoul, Republic of Korea.<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>Leukemia Research Institute, College of Medicine, The Catholic\u00a0University of Korea, Seoul, Korea<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

9<\/span><\/p>\n<\/td>\n

\n

HALVING TIME OF BCR-ABL1 IN\u00a0CHRONIC MYELOID LEUKEMIA, IS IT BETTER THAN A 90 DAY VALUE? A MULTICENTRE
\nSTUDY FROM INDIA<\/span><\/b><\/a><\/p>\n

K<\/span><\/b><\/span>rishnakumar <\/span><\/b><\/span>Rathnam<\/span><\/b><\/span>1<\/span><\/sup><\/span>; Arun <\/span>Seshachalam<\/span><\/span>2<\/span><\/sup><\/span>; Shashidhar <\/span>Karpurmath<\/span><\/span>3<\/span><\/sup><\/span>; Manjunath <\/span>Nandennavar<\/span><\/span>3<\/span><\/sup><\/span>; Kalaiselvi<\/span><\/span><\/span> Selvaraj<\/span><\/span>4<\/span><\/sup><\/span>; Neelesh<\/span><\/span><\/span> Reddy<\/span><\/span>5<\/span><\/sup><\/span>; S<\/span>ringeri <\/span>Roopa<\/span><\/span>5<\/span><\/sup><\/span>; Amula<\/span><\/span><\/span> Sathishkumar<\/span><\/span>5<\/span><\/sup><\/span>; S<\/span>.G. <\/span>Raman<\/span><\/span>6<\/span><\/sup><\/span>; Janardhinakani<\/span><\/span><\/span> Murugesan<\/span><\/span>6<\/span><\/sup><\/span>; Baswant<\/span><\/span><\/span> Mallipatil<\/span><\/span>5<\/span><\/sup><\/span>; Krishnaprasad<\/span><\/span><\/span> Bhat<\/span><\/span>7<\/span><\/sup><\/span>; Krishna <\/span>Reddy<\/span><\/span>8<\/span><\/sup><\/span>; Channappa<\/span> N. <\/span>Patil<\/span><\/span>9<\/span><\/sup><\/span>; Karthik <\/span>Uduppa<\/span><\/span>10<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Meenakshi Mission Hospital & Research Centre,\u00a0Madurai<\/span><\/i><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>GVN Institute of Oncology,\u00a0Trichy<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>Vydehi Institute of Medical\u00a0Sciences, Begaluru<\/span><\/span><\/i><\/span>, <\/span><\/i>4<\/span><\/sup><\/i><\/span>AlIMS, Nagpur<\/span><\/i><\/span>, <\/span><\/i>5<\/span><\/sup><\/i><\/span>Columbia Asia Hospital, Begaluru<\/span><\/span><\/i><\/span>, <\/span><\/i>6<\/span><\/sup><\/i><\/span>Madras Cancer Care Foundation, Chennai<\/span><\/i><\/span>, <\/span><\/i>7<\/span><\/sup><\/i><\/span>Mangalore Institute of Oncology, Mangalore<\/span><\/i><\/span>, <\/span><\/i>8<\/span><\/sup><\/i><\/span>Manipal Hospital, Vijayawada<\/span><\/i><\/span>, <\/span><\/i>9<\/span><\/sup><\/i><\/span>Apollo Hospital, Bengaluru<\/span><\/i><\/span>, <\/span><\/i>10<\/span><\/sup><\/i><\/span>Manipal Hospital, Manipal, India<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/span><\/p>\n<\/td>\n

\n

INTERIM PET SCAN AFTER TWO\u00a0CYCLES OF ABVD CHEMOTHERAPY IS THE STRONGEST PREDICTOR OF OUTCOME IN HODGKIN\u00a0LYMPHOMA: REAL WORLD SCENARIO<\/span><\/b><\/a><\/p>\n

K<\/span><\/b><\/span>rishnakumar <\/span><\/b><\/span>Rathnam<\/span><\/b><\/span>1<\/span><\/sup><\/span>; Arun <\/span>Seshachalam<\/span><\/span>2<\/span><\/sup><\/span>; Shashidhar <\/span>Karpurmath<\/span><\/span>3<\/span><\/sup><\/span>; Krishna Reddy <\/span>Golmari<\/span><\/span>4<\/span><\/sup><\/span>; Ganapahti<\/span> <\/span>Raman<\/span><\/span>5<\/span><\/sup><\/span>; Patil <\/span>Chenappal<\/span><\/span>6<\/span><\/sup><\/span>; Neelesh<\/span> <\/span>Reddy<\/span><\/span>7<\/span><\/sup><\/span>; Krishnaprasad<\/span> <\/span>Bhat<\/span><\/span>8<\/span><\/sup><\/span>; Bharat <\/span>Rangarajan<\/span><\/span>9<\/span><\/sup><\/span>; K<\/span>arthik <\/span>Udupa<\/span><\/span>10<\/span><\/sup><\/span>; M<\/span>anjunath <\/span>Nandennavar<\/span><\/span>3<\/span><\/sup><\/span>; Janardhina<\/span><\/span><\/span> Kani<\/span><\/span>5<\/span><\/sup><\/span>; P<\/span>rasad <\/span>Gunari<\/span><\/span>11<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Meenakshi Mission Hospital & Research Centre,\u00a0Madurai<\/span><\/i><\/span>, <\/span><\/i>2<\/span><\/sup><\/i><\/span>GVN Institute of Oncology,\u00a0Trichy<\/span><\/i><\/span>, <\/span><\/i>3<\/span><\/sup><\/i><\/span>Vydehi Institute of Medical\u00a0Sciences, Begaluru<\/span><\/span><\/i><\/span>, <\/span><\/i>4<\/span><\/sup><\/i><\/span>Manipal Hospital, Vijayawada<\/span><\/i><\/span>, <\/span><\/i>5<\/span><\/sup><\/i><\/span>Madras Cancer Care Foundation, Chennai<\/span><\/i><\/span>, <\/span><\/i>6<\/span><\/sup><\/i><\/span>Apollo Hospital, Bengaluru<\/span><\/i><\/span>, <\/span><\/i>7<\/span><\/sup><\/i><\/span>Columbia Asia Jospital<\/span>, Begaluru<\/span><\/span><\/i><\/span>, <\/span><\/i>8<\/span><\/sup><\/i><\/span>Mangalore Institute of Oncology, Mangalore<\/span><\/i><\/span>, <\/span><\/i>9<\/span><\/sup><\/i><\/span>Kovai Medical Centre, Coimbatore<\/span><\/i><\/span>, <\/span><\/i>10<\/span><\/sup><\/i><\/span>Manipal Hospital, Manipal<\/span><\/i><\/span>, <\/span><\/i>11<\/span><\/sup><\/i><\/span>HCG Cancer Centre, Hubli, India<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

11<\/span><\/p>\n<\/td>\n

\n

ADAMTS 13 LEVELS AND VON\u00a0WILLEBRAND FACTOR (VWF) COLLAGEN ACTIVITY IN DENGUE FEVER (AVID STUDY)<\/span><\/b><\/a><\/p>\n

J<\/span><\/b><\/span>ayastu<\/span><\/b><\/span><\/span> <\/b>Senapati<\/span><\/b><\/span>1<\/span><\/sup><\/span>; S<\/span>owmya <\/span>Satheyndra<\/span><\/span>2<\/span><\/sup><\/span><\/p>\n

1<\/span><\/sup><\/i><\/span>Department of Clinical Haematology\u00a0<\/span>and <\/span><\/i><\/span>2<\/span><\/sup><\/i><\/span>Department of Medicine, <\/span><\/i><\/span>Christian Medical College and\u00a0Hospital, Vellore, India<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n

\n

12<\/span><\/p>\n<\/td>\n

\n

EVALUATION OF CHRONIC MIELOID\u00a0LEUKEMIA DISTRIBUTION, DIAGNOSTICS AND TREATMENT IN AZERBAIJAN<\/span><\/b><\/a><\/p>\n

A<\/span><\/b><\/span>yten<\/span><\/b><\/span><\/span> <\/b>Shirinova<\/span><\/b><\/span><\/span>; Aypara<\/span> <\/span>Hasanova<\/span><\/span><\/span>; Chingiz<\/span> <\/span>Asadov<\/span><\/span><\/span>; Zohra Alimirzoyeva<\/span><\/span><\/span><\/span><\/p>\n

Institute\u00a0of Hematology and Transfuziology<\/span>, Baku, Azerbaijan<\/span><\/i><\/span><\/i><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"yst_prominent_words":[400,405,413,394,398,393,395,399,396,417,403,418,397,416,402,414,404,401,419,415],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12053"}],"collection":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/comments?post=12053"}],"version-history":[{"count":0,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12053\/revisions"}],"wp:attachment":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/media?parent=12053"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/yst_prominent_words?post=12053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}